Integrated Systems Analysis Deciphers Transcriptome and Glycoproteome Links in Alzheimer's Disease

Area of Science:

• Neuroscience
• Biochemistry
• Glycobiology

Background:

• Glycosylation is a critical post-translational modification implicated in Alzheimer's disease (AD).
• Specific glycoproteins are altered in AD, but the regulatory mechanisms and cell-type specificity remain unclear.

Purpose of the Study:

• To investigate upstream regulators of aberrant glycosylation in Alzheimer's disease.
• To elucidate the role of specific glycosyltransferases in AD pathogenesis.

Main Methods:

• A glycogenomics approach integrating multiple data sources.
• Analysis of dysregulated glycosyltransferases and their downstream effects.

Main Results:

• Dysregulation of the glycosyltransferase PLOD3 in oligodendrocytes was identified as an upstream regulator.
• PLOD3 is involved in COL4A5 synthesis, which correlates with amyloid fiber formation.
• COL4A5 may interact with astrocytes via extracellular matrix receptors.

Conclusions:

• PLOD3 in oligodendrocytes is a potential therapeutic target in Alzheimer's disease.
• Targeting glycosyltransferases like PLOD3 may offer novel strategies for AD treatment.